SJL2-1
SJL2-1 is a PRMT5 inhibitor, with an IC50 of 1.56 μM. SJL2-1 suppresses proliferation, migration, and invasion in prostate cancer cells. SJL2-1 promotes apoptosis and blocks the cell cycle at the G0/G1 phase. SJL2-1 can target the binding of PRMT5 in cells and inhibit the methylation and expression of the androgen receptor. SJL2-1 can be used for the study of early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC) [1].
Product Specifications
UNSPSC
12352005
Target
11β-HSD; Androgen Receptor; Histone Methyltransferase
Related Pathways
Epigenetics; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1=CN(CC(CN2C(C)C(C=CC=C3)=C3CC2)O)C4=CC=CC=C41
Molecular Formula
C22H26N2O
Molecular Weight
334.45
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse ADP ribosylation factor binding protein GGA2 (GGA2) ELISA kit
Lentiviral mouse AU022751 shRNA (UAS) - Lentiviral mouse AU022751 shRNA (UAS) (25)
IGF2-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)